1. The fate of [14C]thalidomide orally administered to pregnant rabbits at the beginning of the sensitive phase of pregnancy has been studied. 2. After the oral administration of [14C]thalidomide on the 192nd hour of pregnancy about 68% of the radioactivity appears in the urine and 22% in the faeces. 3. The urinary 14C is made up as follows (% of dose): thalidomide (2); a-(o-carboxybenzamido)glutarimide (16); 2-and 4-phthalimidoglutaramic acids (11); 2-phthalimidoglutaric acid (0.2); 2-and 4-(o-carboxybenzamido)glutaramic acids and 2-(o-carboxybenzamido)-glutaric acid (29). 4. The plasma 14C concentration is maximal at 12hr. after dosing and the radioactivity persists for more than 58hr. At 4hr. the main compound in the plasma is thalidomide, but its concentration steadily declines while the concentration of its hydrolysis products increases. 5. At 12, 24 and 58hr. after dosing radioactivity is present in the embryo and the maternal tissues examined. The 14C concentration in the embryo is at nearly all times higher than that in the plasma, brain, skeletal muscle and fat but lower than that in the liver and kidney. 6. At 4hr. after dosing the mother on the tenth day of pregnancy the specific activities of the embryo and the yolk-sac fluid are similar. 7. Thalidomide is found in the embryo together with seven of its hydrolysis products for more than 24hr. after dosing. The accumulation of radioactivity in the embryo is due to retention of the polar hydrolysis products.
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Previous studies from this Laboratory have
shown that the embryo of the New Zealand WVhite rabbit is sensitive to the teratogenic effect of thalidomide during a period of 58hr. extending from the 192nd to 250th hour of pregnancy (Fabro & Smith, 1966 (Bromborough Port, Cheshire). Phthalic acid, m.p. 219°, was purchased. (± )-2-and (± )-4-Phthalimidoglutaramic acids, (± )-2-phthalimidoglutaric acid, (± )-4-(o-carboxybenzamido)glutaramic acid and (± )-a-aminoglutarimide were samples previously prepared . (±)-a-(o-Carboxybenzamido)glutarimide, m.p. 268-270°, was prepared from phthalic anhydride and cc-aminoglutarimide (Sondheimer & Holley, 1957) by the method of Beckmann (1963) .
Animal experiments. Adult New Zealand White does (3-4kg. body wt.) were mated with bucks ofthe same breed. Immediately after copulation the female was removed from the cage of the male and the time of mating was taken as hour zero of the pregnancy. The pregnant animals were allowed free access to food and water, and on the 192nd hour of pregnancy they were each given, by stomach tube,
[14C]thalidomide (150mg./kg.; 5 tLc/kg.) suspended in about 20ml. of water. This dose is teratogenic in this breed of rabbit (Fabro & Smith, 1966 In some experiments, the samples were burned in a Schoniger flask to 14CO2, which was collected in M-Hyamine hydroxide in methanol (lOml.) (Kelly, Peets, Gordon & Buyske, 1961) . The Hyamine solution (3ml.) was transferred to glass counting vials containing 17ml. of scintillation fluid B [toluene containing 2,5-diphenyloxazole (0.5%) and 1,4-bis-(5-phenyloxazol-2-yl)benzene (0.03%)].
14C was counted in a Packard Tri-Carb liquid-scintillation spectrometer (model 3214). Blanks were prepared from the tissues of untreated pregnant does. Counting efficiency was measured by the twin-channel-ratio method (Bush, 1963) . For samples with low radioactivity (i.e. counting rate leas than three times that of background), the efficiency was measured by the internal-standard method.
Identification of 14C-labelled compound8. Radioactive compounds in the embryo, maternal tissues and exereta were identified by a reverse isotope-dilution technique after a preliminary chromatographic separation. Pooled homogenized embryos (six to ten) were freeze-dried to a yellowish-red powder, which was extracted three times with methanol (10ml.). After centrifuging, the extract was concentrated under reduced pressure at 300 to 2ml. in a rotary evaporator. Samples (0-3-0-5ml.) of the extract were dried as a spot on Whatman no. 1 paper. Over this spot was applied 0-1 ml. of a methanolic solution containing 50,ug. of each of the carrier compounds, namely thalidomide, 2-and 4-phthalimidoglutaramic acid, 2-phthalimidoglutaric acid, a-(o-carboxybenzamido)glutarimide, 2-and 4-(o-carboxybenzamido)glutaramic acids, 2-(o-carboxybenzamido)glutaric acid and phthalic acid. The chromatograms were developed in two dimensions with the solvent systems of Schumacher et al. (1965) . After being dried, the chromatograms were examined in ultraviolet light (Chromatolite lamp, peak emission 254m,) before and after hydrazine treatment as described by Schumacher et al. (1965) . The compounds were identified by comparing their Bp values and colour reactions with those of authentic samples . Maternal plasma (lOml.) was similarly freeze-dried and treated as above. With urine and faecal extracts, samples (0-1 ml.) were applied directly to the paper.
For estimation of 14C, areas of the paper chromatogram, known to contain specific compounds, were cut out and transferred to counting vials containing 20ml. of scintillation fluid B. The rest of the chromatogram was similarly cut into pieces of about 3 cm. x 3 cm. and counted. The total 14C on the chromatogram was then estimated, and, after correction for background, the 14C associated with each compound was calculated as a percentage of the total.
RESULTS AND DISCUSSION
The embryo of the New Zealand White rabbit is sensitive to the teratogenic effect of thalidomide for a period of about 58hr., that is from the 192nd to the 250th hour of pregnancy (Fabro & Smith, 1966) . If the mother is given an oral dose of the drug of 150mg./kg. at the beginning of this period, then by the end of this time some 90% is eliminated, about 70% in the urine and 20% in the faeces (Table 1) . (rabbits 1-3) 62-7 (60-2-65-3) 17-0 (13-6-20-0) 8-1 (6-3-9-3) 87-8 (84-0-91-3) At 58hr.
(rabbits 4-6) 67-9 (66-1-70-3) 21-6 (17-7-24-8) 3-4 (2-4-4-3) 92-8 (87-2-96-9) The urinary material contains only 2% of the dose as unchanged thalidomide, the rest being hydrolysis products. The faecal material, however, is largely unchanged thalidomide, with smaller amounts of the hydrolysis products, the main one being a -(o -carboxybenzamido)glutarimide (Table 2) . Thalidomide at this dosage is thus fairly well absorbed from the intestine by the pregnant rabbit. The plasma radioactivity, shown in Fig. 1, reaches plasma at various times up to 24hr. after dosing is r dosing (hr.) shown in Table 3 . This Table shows 12hr. 24hr. is reversed.
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The distribution of 14C in the embryo and 1-7 11.4 4-3 maternal tissues at various times (12, 24 and 58hr.) after the thalidomide dose is shown in Table 4 .
Radioactivity is present in all the tissues examined, 0.5 0.5 and that in the embryo is, at nearly all the times 2-8 1-6 quoted, higher than that in the plasma, brain, skeletal muscle and fat but lower than that in the liver and kidney. The distribution of 14C in the 10-day rabbit conceptus at 4hr. after dosing the mother orally with thalidomide is shown in Table 5 . The radioactivity is approximately uniformly distributed between the embryo and the yolk-sac fluid. Radioactivity tends to accumulate in the embryo for at least 24hr., since the embryo 14C-maternal-plasma 14C concentration ratio increases during the first 24hr. after dosing (see Table 6 ). At 4hr. this ratio is about 0-5, increasing to 1-4 at 12 hr. and 2-4 at 24hr.; at 58hr. the ratio has declined to about 1-6. Thalidomide itself is present in the embryo throughout the 24hr. after dosing the mother, in amounts declining with time (Table 7) . The primary hydrolysis products are detectable in the embryo after 4hr. and they increase in amount, especially a -(o -carboxybenzamido)glutarimide. The secondary hydrolysis products are also detectable at 12hr. At 24hr. the amounts of the hydrolysis products in the embryo are slightly less than they were at 12hr., except for 2-and 4-phthalimidoglutaramic acids, which are now slightly more. The ratios of the concentrations of thalidomide and its hydrolysis products in the embryo to those in the maternal plasma are shown in Table 8 . These ratios increase withtime, indicating the accumulation ofthalidomide and its breakdown products in the embryo. It is thus clear that, when thalidomide is administered orally to the mother, it can penetrate into the embryo and remains there partly as such for at least 24hr., despite the fact that it is undergoing spontaneous hydrolysis. A possible reason for this accumulation is that, whereas thalidomide is lipid-soluble and less polar than its hydrolysis products, the latter are all polar compounds and probably less lipid-soluble at physiological pH Vol. 104 
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values. Thus thalidomide could penetrate the embryo easily and then hydrolyse spontaneously to polar products that cannot readily leave the embryo. It is thus possible that the teratogenic effect of thalidomide is mediated through one or more of its hydrolysis products, since they occur in the embryo. However, none of these products has been found to be teratogenic in the rabbit when given by mouth (Fabro, Schumacher, Stagg, Smith & Williams, 1965; Keberle et al. 1965a; Keberle, Loustalot, Maller, Faigle & Schmid, 1965b) , but this could be explained by suggesting that as such they do not penetrate into the embryo and could only be effective teratogenic agents if they are formed from thalidomide in the embryo itself. The problem of whether some of these hydrolysis products can penetrate into the embryo when given by mouth is dealt with in the succeeding paper (Fabro, Smith & Williams, 1967) .
